Parliamentary Panel calls for setting up of a platform CTMS for Ayush clinical research
|
Gireesh Babu, New Delhi
March 19 , 2025
|
|
The Parliamentary Panel on Union Health Ministry has called for setting up of a robust Clinical Trial Management System (CTMS) for Ayush clinical research, bringing all research councils, institutes and other autonomous research bodies on a single platform.
The Parliamentary Standing Committee on Health and Family Welfare, in its 165th report on Demands for Grants 2025-26 of the Ministry of Ayush, also expressed its desire that information on reported claims regarding Ayush treatments supported by research-based evidence may also be provided along with this.
"The Committee is of the considered view that implementing a robust Clinical Trial Management System (CTMS) will significantly improve documentation, efficiency, and compliance in Ayush clinical research. All the research councils, institutes and other autonomous bodies engaged in R&D, clinic trials and related activities should be brought onto this single platform," said the panel headed by Member of Rajya Sabha Prof. Ram Gopal Yadav, in the latest report.
Automation of key trial processes, including patient recruitment, randomization, monitoring, adverse event reporting, and regulatory submissions, will enhance efficiency. By automating workflows, it will reduce manual errors, enhance regulatory transparency, and accelerate trial approvals.
Standardizing research protocols with ICMR/GCP guidelines will ensure uniformity across Ayush disciplines, strengthening the scientific validation of traditional medicine. AI-driven analytics will support data-driven decision-making, enabling better tracking of adverse events and treatment outcomes.
"Furthermore, a well-integrated CTMS will allow multi centre trials, facilitating global acceptance of Ayush-based interventions and positioning India as a leader in integrative medicine research," it added.
At present, the Clinical Trials Registry-India (CTRI), hosted at the ICMR’s National Institute of Medical Statistics, has data sets specific to the Ayush system of medicine where Ayush-specific information is being captured during the trial registration process.
The information on R&D protocol, approval and subsequent outcomes is maintained separately at respective institutes, research councils and other autonomous bodies etc.
Clinical trials of the Central Council for Research in Ayurvedic Sciences (CCRAS) are monitored through an elaborated mechanism of Electronic Data Capture (EDC), which is scrutinised at the headquarters level. Central Council for Research in Homeopathy (CCRH) is registering all its clinical trials on Clinical trial Registry of India before initiation of its research project.
National Institute of Ayurveda (NIA) has established a project management Unit to develop a robust CTMS and also launched Intra Mural Research (IMR) Policy for better R&D outcomes. NIA has also developed Drug development and Discovery Unit (DDDU) for development of New Drugs, observes the Panel.
"The Committee further desires that information on reported claims regarding Ayush treatment for controlling cholesterol levels using tablets or injections, supported by research-based evidence, if available, may be provided," added the Panel.
|

|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|